Associations between AR-V7 status in circulating tumour cells, circulating tumour cell count and survival in men with metastatic castration-resistant prostate cancer

European Journal of Cancer ◽

10.1016/j.ejca.2019.08.005 ◽

2019 ◽

Vol 121 ◽

pp. 48-54 ◽

Cited By ~ 3

Author(s):

Bodine P.S. Belderbos ◽

Anieta M. Sieuwerts ◽

Esther Oomen-de Hoop ◽

Bianca Mostert ◽

Jaco Kraan ◽

...

Keyword(s):

Prostate Cancer ◽

Cell Count ◽

Tumour Cell ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Circulating Tumour Cell

Download Full-text

Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2019.04.006 ◽

2019 ◽

Vol 76 (5) ◽

pp. 676-685 ◽

Cited By ~ 22

Author(s):

Adam Sharp ◽

Jon C. Welti ◽

Maryou B.K. Lambros ◽

David Dolling ◽

Daniel Nava Rodrigues ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumour Cell ◽

Splice Variant ◽

Clinical Utility ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Circulating Tumour Cell ◽

Androgen Receptor Splice Variant

Download Full-text

Preliminary circulating tumour cell (CTC) analysis in phase II study of weekly cabazitaxel for "unfit" metastatic castration resistant prostate cancer patients (mCRPC) progressing after docetaxel treatment (SOGUG-CABASEM trial).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.e16034 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. e16034-e16034

Author(s):

Luis Leon Mateos ◽

Laura Muinelo ◽

Begoña Perez-Valderrama ◽

Begoña Mellado ◽

María José Juan Fita ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Tumour Cell ◽

Phase Ii Study ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Docetaxel Treatment ◽

Circulating Tumour Cell

Download Full-text

Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer

European Journal of Cancer ◽

10.1016/j.ejca.2021.02.042 ◽

2021 ◽

Vol 150 ◽

pp. 83-94

Author(s):

H.I. Scher ◽

A.J. Armstrong ◽

J.D. Schonhoft ◽

A. Gill ◽

J.L. Zhao ◽

...

Keyword(s):

Prostate Cancer ◽

Tumour Cell ◽

Prognostic Biomarker ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Circulating Tumour Cell ◽

Cell Enumeration ◽

Development And Validation

Download Full-text

P055 Changes in prostate-specific antigen levels are not associated with changes in circulating tumour cells levels during chemotherapy in castration-resistant prostate cancer

European Urology Supplements ◽

10.1016/s1569-9056(14)61278-1 ◽

2014 ◽

Vol 13 (5) ◽

pp. 129

Author(s):

O. Čapoun ◽

M. Jančíková ◽

V. Mikulová ◽

H. Honová ◽

K. Kološtová ◽

...

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Re: Christof Bernemann, Thomas J. Schnoeller, Manuel Luedeke, et al. Expression of AR-V7 in Circulating Tumour Cells Does Not Preclude Response to Next Generation Androgen Deprivation Therapy in Patients with Castration Resistant Prostate Cancer. Eur Urol 2017;71:1–3

European Urology ◽

10.1016/j.eururo.2016.09.021 ◽

2017 ◽

Vol 71 (4) ◽

pp. e105-e106 ◽

Cited By ~ 1

Author(s):

Marcus V. Cronauer ◽

Axel S. Merseburger ◽

M. Raschid Hoda

Keyword(s):

Prostate Cancer ◽

Androgen Deprivation Therapy ◽

Androgen Deprivation ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Next Generation ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Circulating tumour cells (CTC) count and prostate-specific antigen (PSA) response measures in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with docetaxel (Doc)

Annals of Oncology ◽

10.1093/annonc/mdz248.046 ◽

2019 ◽

Vol 30 ◽

pp. v350

Author(s):

R Lozano Mejorada ◽

D. Lorente ◽

E. Castro ◽

D. Bianchini ◽

P. Nombela ◽

...

Keyword(s):

Prostate Cancer ◽

Prostate Specific Antigen ◽

Specific Antigen ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Psa Response ◽

Response Measures

Download Full-text

CTC-STOP Trial: A trial to determine if the use of Circulating Tumour Cell (CTC) counts can direct early discontinuation of docetaxel chemotherapy in patients with metastatic castration resistant prostate cancer (mCRPC), when compared with standard approaches to guide treatment switch decisions

http://isrctn.com/ ◽

10.1186/isrctn82499869 ◽

2017 ◽

Author(s):

Marie Hyslop

Keyword(s):

Prostate Cancer ◽

Tumour Cell ◽

Castration Resistant Prostate Cancer ◽

Early Discontinuation ◽

Castration Resistant ◽

Stop Trial ◽

Circulating Tumour Cell ◽

Treatment Switch ◽

Docetaxel Chemotherapy

Download Full-text

701 IMMUNOMAGNETIC QUANTIFICATION OF CIRCULATING TUMOUR CELLS (CTCS) AS NEW PROGNOSTIC AND PREDICTIVE FACTOR IN CASTRATION RESISTANT PROSTATE CANCER (CRPC): PRELIMINARY RESULTS

European Urology Supplements ◽

10.1016/s1569-9056(09)60695-3 ◽

2009 ◽

Vol 8 (4) ◽

pp. 296

Author(s):

Rocca M. Cossu ◽

E. Verri ◽

M.T. Sandri ◽

C. Marenghi ◽

E. Botteri ◽

...

Keyword(s):

Prostate Cancer ◽

Predictive Factor ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Castration Resistant Prostate Cancer ◽

Preliminary Results ◽

Castration Resistant

Download Full-text

Circulating tumour cells in patients with metastatic castration resistant prostate cancer under treatment with cabazitaxel - a prospective biomarker study from the Hellenic Oncology Research Group

European Urology Supplements ◽

10.1016/s1569-9056(19)30871-1 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1213-e1214

Author(s):

Z. Zafeiriou ◽

N. Kostakopoulos ◽

Z. Messaritakis ◽

E. Bournakis ◽

A. Kotsakis ◽

...

Keyword(s):

Prostate Cancer ◽

Research Group ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Oncology Research

Download Full-text

675P HER2 expression in circulating tumour cells is associated with poor outcomes in patients with metastatic castration resistant prostate cancer

Annals of Oncology ◽

10.1016/j.annonc.2020.08.934 ◽

2020 ◽

Vol 31 ◽

pp. S540

Author(s):

D. Maillet ◽

N. Allioli ◽

J. Peron ◽

A. Plesa ◽

M. Decaussin ◽

...

Keyword(s):

Prostate Cancer ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Her2 Expression ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Poor Outcomes

Download Full-text